IL6 and lung carcinoma: In this regard, previous studies published by our group showed that tumor-associated lymphocytes from pleural neoplastic effusions of patients with lung cancer are defective in terms of proliferative response and immune functions, although they can release high amounts of various cytokines, especially IL-6 [84,85].